EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

MicroRNA ‐210 level as a biomarker for pre‐eclampsia severity: A systematic review and meta‐analysis

Dávid Márai iD, Isabel Pinto Amorim das Virgens, Ádám Vincze, Mahmoud Obeidat, Péter Hegyi, Mikolt Bakony, Zsófia Réka Erdélyi, Zsolt Melczer, Sándor Valent iD

International Journal of Gynecology & Obstetrics · 2026-12 · 175 (3) · 1177-1187

DOI: 10.1002/ijgo.71145 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 23.06.2026. Verfasst von Dávid Márai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Medicine, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Pre-Eclampsia, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pre‐eclampsia is a serious pregnancy‐related syndrome lacking accurate prognostic markers. MicroRNA‐210, overexpressed in the circulation of women with pre‐eclampsia, has recently emerged as a promising biomarker.

Objectives

We conducted a systematic review and meta‐analysis to evaluate the relationship between miR‐210 levels and pre‐eclampsia at different degrees of severity. Search Strategy The study was prospectively registered on PROSPERO (CRD42024604698) and included a comprehensive systematic search of five databases conducted on November 21, 2024. Selection Criteria, Data Collection and Analysis The included studies involved pregnant women with mild or severe pre‐eclampsia compared to normotensive controls, meeting guideline‐based diagnostic criteria and reporting circulating microRNA‐210. Precalculated effect sizes were pooled to obtain a weighted mean and 95% confidence interval (CI) for microRNA‐210‐fold increase. Subgroup analysis assessed pre‐eclampsia severity, using an inverse variance method in random‐effects meta‐analysis models. Main Results Our search identified 776 records, of which seven were deemed eligible for analysis. The fold change values, reflecting the increase in microRNA‐210 levels between the control and pre‐eclamptic populations, were 3.33 (CI: 0.69–5.98; I 2 = 93%, CI: 88–96%) in the mild pre‐eclampsia group and 7.23 (CI: 2.27–12.18; I 2 = 98%, CI: 98–99%) in the severe pre‐eclampsia group, indicating a significant effect ( P = 0.01) in the subgroup difference tests. The mean ratio of microRNA‐210‐fold change between the two severity groups was 2.05 (CI: 1.41–2.69; I 2 = 85%, P < 0.01), favoring the severe population.

Conclusion

Elevated microRNA‐210 levels are strongly associated with pre‐eclampsia severity at the time of diagnosis, with a consistent, significant stepwise increase from mild to severe disease. Whether miR‐210 holds predictive value earlier in pregnancy remains to be established in prospective studies with first‐trimester sampling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaMicroRNAsHumansFemalePregnancyBiomarkersSeverity of Illness Index

Stichwörter der Autor:innen

PEmiRNAmiRNA‐210miR‐210microRNApre‐eclampsiaprognostic markersevere PE

Substanzen

MicroRNAsMIRN210 microRNA, humanBiomarkers

Autor:innen und Institutionen

  • Center for Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.
  • Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
  • Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary.

ORCID-Profile: Dávid Márai, Sándor Valent

Zitieren

APA

Márai, D., Virgens, I. P. A. D., Vincze, Á., Obeidat, M., Hegyi, P., Bakony, M., Erdélyi, Z. R., Melczer, Z., & Valent, S. (2026). MicroRNA ‐210 level as a biomarker for pre‐eclampsia severity: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics, 175(3), 1177-1187. https://doi.org/10.1002/ijgo.71145

Vancouver

Márai D, Virgens IPAD, Vincze Á, Obeidat M, Hegyi P, Bakony M, et al. MicroRNA ‐210 level as a biomarker for pre‐eclampsia severity: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. 2026;175(3):1177-1187. doi:10.1002/ijgo.71145

BibTeX
@article{Mrai2026,
  author = {Márai, Dávid and Virgens, Isabel Pinto Amorim das and Vincze, Ádám and Obeidat, Mahmoud and Hegyi, Péter and Bakony, Mikolt and Erdélyi, Zsófia Réka and Melczer, Zsolt and Valent, Sándor},
  title = {MicroRNA ‐210 level as a biomarker for pre‐eclampsia severity: A systematic review and meta‐analysis},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  volume = {175},
  number = {3},
  pages = {1177--1187},
  doi = {10.1002/ijgo.71145}
}
Kostenlos starten →